Dr. Eric Kauffman shares our strategy for the active surveillance, or "watchful waiting,” approach to kidney cancer. Active surveillance allows some patients with small and slow-growing tumors to choose careful monitoring of their cancer, rather than undergo immediate treatment.

свернуть